On May 22, 2025, Teladoc Health, Inc. held its Annual Meeting where shareholders approved an amendment to increase the shares available under the Incentive Award Plan by 6.85 million shares, and directors were elected with various voting results. The shareholders also approved the compensation for executives and ratified Ernst & Young as the accounting firm for 2025.